semaglutide (Lexaria Bioscience)

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug Namesemaglutide (Lexaria Bioscience)
Drug Alias NameDehydraTECH (Lexaria Bioscience)DehydraTECH-powered semaglutideDehydraTECH-GLP1 (Lexaria Bioscience)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesLexaria Bioscience Corp
China Registration ClassN/A

Develop Information

Active CompaniesLexaria Bioscience Corp
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A